Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOMA1-IR vs HOMA2-IR for Ovulation Prediction in PCOS
NCT06793904Recruiting
- Sponsor
- Cairo University
- Start
- Feb 2025
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of letrozole in infertility and polycystic ovary syndrome (PCOS), sponsored by Cairo University. Primary endpoint: Number of participants with successful ovulation. Started Feb 2025; status: recruiting.
02
Drugs
letrozole
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06793904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06793904.